Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase 3 CELESTIAL trial.

Abou-Alfa G. K., Meyer T., Cheng A., El-Khoueiry A., Rimassa L., Ryoo B., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.36, sa.15, 2018 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Cilt numarası: 36 Sayı: 15
• Basım Tarihi: 2018
• Doi Numarası: 10.1200/jco.2018.36.15_suppl.4019
• Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Trakya Üniversitesi Adresli: Evet